1.
Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trial
by Fayad, Zahi A, Prof
The Lancet (British edition), 2011, Vol.378 (9802), p.1547-1559
2.
Lupus Atherosclerosis Prevention Study (LAPS)
by Petri, M A
Annals of the rheumatic diseases, 2011-05, Vol.70 (5), p.760-765
3.
Longitudinal cohort study on the effectiveness of lipid apheresis treatment to reduce high lipoprotein(a) levels and prevent major adverse coronary events
by Jaeger, Beate R
Nature clinical practice cardiovascular medicine, 2009-03, Vol.6 (3), p.229-239
4.
Antiplatelet therapy for secondary prevention of coronary artery disease
by Pilgrim, Thomas
Heart, 2014-11, Vol.100 (22), p.1750-1756
5.
Serum oxidized low-density lipoprotein decreases in response to statin therapy and relates independently to reductions in coronary plaque in patients with HIV
by Nou, Eric
AIDS (London), 2016-02-20, Vol.30 (4), p.583-590
6.
Role of Vitamin D in Cardiovascular Health
by Reddy Vanga, Subba, MBBS
The American journal of cardiology, 2010, Vol.106 (6), p.798-805
7.
Effects of grape seed proanthocyanidin extract on menopausal symptoms, body composition, and cardiovascular parameters in middle-aged women: a randomized, double-blind, placebo-con...
by Terauchi, Masakazu
Menopause (New York, N.Y.), 2014-09, Vol.21 (9), p.990-996
8.
Effects of Plant-Based Diets on Plasma Lipids
by Ferdowsian, Hope R., MD, MPH
The American journal of cardiology, 2009, Vol.104 (7), p.947-956
9.
Value of Coronary Computed Tomography Angiography in Tailoring Aspirin Therapy for Primary Prevention of Atherosclerotic Events in Patients at High Risk With Diabetes Mellitus
by Dimitriu-Leen, Aukelien C., MD
The American journal of cardiology, 2016, Vol.117 (6), p.887-893
10.
Results of the National Cholesterol Education (NCEP) Program Evaluation Project Utilizing Novel E-Technology (NEPTUNE) II Survey and Implications for Treatment Under the Recent NCE...
by Davidson, Michael H
The American journal of cardiology, 2005, Vol.96 (4), p.556-563
11.
Recent findings of long-chain n -3 polyunsaturated fatty acids (LC n -3 PUFAs) on atherosclerosis and coronary heart disease (CHD) contrasting studies in Western countries to Japan
by Sekikawa, Akira, MD, PhD
Trends in cardiovascular medicine, 2015, Vol.25 (8), p.717-723
12.
Statins and myocardial infarction: Type, dose and administration time –does it matter?
by Papageorgiou, Nikolaos, MD PhD
Trends in cardiovascular medicine, 2016, Vol.26 (5), p.433-441
13.
Effect of Rosuvastatin on Coronary Flow Reserve in Patients With Systemic Hypertension
by Sun, Byung Joo, MD
The American journal of cardiology, 2014, Vol.114 (8), p.1234-1237
14.
Efficacy and Safety of Ezetimibe Added on to Atorvastatin (20 mg) Versus Uptitration of Atorvastatin (to 40 mg) in Hypercholesterolemic Patients at Moderately High Risk for Coronar...
by Conard, Scott E., MD
The American journal of cardiology, 2008, Vol.102 (11), p.1489-1494
15.
Short-term effects of low-dose estradiol on endothelial function and blood viscosity in nondiabetic postmenopausal overweight women: a double-blind, placebo-controlled study
by Panazzolo, Diogo G
Menopause (New York, N.Y.), 2016-10, Vol.23 (10), p.1114-1121
16.
Improved treatment of coronary heart disease by implementation of a Cardiac Hospitalization Atherosclerosis Management Program (CHAMP)
by Fonarow, Gregg C
The American journal of cardiology, 2001, Vol.87 (7), p.819-822
17.
Effect of a Telephone-Delivered Coronary Heart Disease Secondary Prevention Program (ProActive Heart) on Quality of Life and Health Behaviours: Primary Outcomes of a Randomised Con...
by Hawkes, Anna L
International journal of behavioral medicine, 2012-07-18, Vol.20 (3), p.413-424
18.
Effect of Intensive Lipid Lowering on Progression of Coronary Atherosclerosis: Evidence for an Early Benefit from the Reversal of Atherosclerosis with Aggressive Lipid Lowering (RE...
by Nissen, Steven E
The American journal of cardiology, 2005, Vol.96 (5), p.61-68
19.
Antiinflammatory and Antiarteriosclerotic Effects of Pioglitazone
by Ishibashi, Minako
Hypertension (Dallas, Tex. 1979), 2002-11, Vol.40 (5), p.687-693
20.
Impact of Adding Ezetimibe to Statin to Achieve Low-Density Lipoprotein Cholesterol Goal (from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation [COU...
by Maron, David J., MD
The American journal of cardiology, 2013, Vol.111 (11), p.1557-1562
Filter electronic articles 342 Hits
Remove Filters
- Subjects
- Treatment Outcome
- Humans (339)
- Science & Technology (287)
- more ...